Clinical trial
A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based…
NCT00166712 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00166712 |
|---|---|
| Title | A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression |
| Official title | A Phase IV, Single Center Pilot Study Using Alemtuzumab (Campath-1H) Induction Combined With Prednisone-Free, Calcineurin-Inhibitor-Free Immunosuppression in Kidney Transplantation |
| Acronym | Cell220 |
| Lead sponsor | Northwestern University, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplant Failure and Rejection |
| Intervention type | Drug |
| Interventions | Tacrolimus (TAC), Sirolimus, Alemtuzumab, Mycophenolate mofetil (MMF) |
| Enrollment | 40 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 26, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: